4.2 Article

The role of decidual regulatory T cells in the induction and maintenance of fetal antigen-specific tolerance: Imbalance between regulatory and cytotoxic T cells in pregnancy complications

期刊

HUMAN IMMUNOLOGY
卷 82, 期 5, 页码 346-352

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.humimm.2021.01.019

关键词

cytotoxic T cell; Pregnancy; Miscarriage; Preeclampsia; regulatory T cell

资金

  1. Ministry of Education, Culture, Sports, Science and Technology in Japan (KAKENHI) [19 K18690]
  2. Tamura Science & Technology Foundation, Toyama, Japan
  3. First Bank of Toyama Scholarship Foundation Research Grant, Toyama, Japan
  4. AMED [JP20gk011004]

向作者/读者索取更多资源

Fetal antigen-specific tolerance is crucial for maintaining allogeneic pregnancies, with a key role played by Treg cells. Insufficient or dysfunctional Treg cells may contribute to the pathogenesis of complications such as miscarriage and preeclampsia in pregnancy.
Fetal antigen-specific tolerance is important for maintaining allogeneic pregnancies. Maternal conventional T cells recognize fetal antigens; however, regulatory T (Treg) cells suppress immune reactions against the fetus. Fetal antigen-specific Treg cells are induced in the decidua upon contact with antigen-presenting cells and extravillous trophoblasts (EVTs). Functional alteration of cytotoxic T cells (CTLs) in the decidua also contributes to maintaining the pregnancy. Reduced, dysfunctional, and imbalanced Treg cell distribution likely contributes to the pathogenesis of pregnancy complications, such as miscarriage and preeclampsia. Recent studies have revealed differences in Treg cell characteristics during preeclampsia and miscarriage. Treg cell reduction in the decidua is likely associated with miscarriage. Insufficient expansion of fetal antigen-specific Treg cells in the decidua probably plays a role in preeclampsia pathogenesis. In addition, the balance between Treg cell-mediated tolerance and functional alteration of CTLs is important. Further investigations of functional molecules in Treg cells will contribute to the development of immunotherapy for pregnancy complications. (c) 2021 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据